Biotech M&A, the one thing that might offset overwhelming funding fears crippling the share prices of most non-FCF companies on the ASX, has been very quiet of late. Let's hope PR finally fulfills on one of those long hinted at partnerships.....
PAR. SP, page-361
-
- There are more pages in this discussion • 791 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.015(5.88%) |
Mkt cap ! $84.05M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.5¢ | 24.0¢ | $167.2K | 671.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 108741 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 9700 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |